166 related articles for article (PubMed ID: 1848340)
21. Discriminative stimulus- and open-field effects of the enantiomers of 11-hydroxy-delta-8-tetrahydrocannabinol in pigeons and gerbils.
Järbe TU; Mechoulam R; Zahalka J
Pharmacol Biochem Behav; 1994 Jan; 47(1):113-9. PubMed ID: 8115412
[TBL] [Abstract][Full Text] [Related]
22. Regulation of adenylate cyclase by cannabinoid drugs. Insights based on thermodynamic studies.
Howlett AC; Scott DK; Wilken GH
Biochem Pharmacol; 1989 Oct; 38(19):3297-304. PubMed ID: 2554920
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of the cyclic AMP signaling cascade and nuclear factor binding to CRE and kappaB elements by cannabinol, a minimally CNS-active cannabinoid.
Herring AC; Koh WS; Kaminski NE
Biochem Pharmacol; 1998 Apr; 55(7):1013-23. PubMed ID: 9605425
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus type 1 Tat protein decreases cyclic AMP synthesis in rat microglia cultures.
Patrizio M; Colucci M; Levi G
J Neurochem; 2001 Apr; 77(2):399-407. PubMed ID: 11299302
[TBL] [Abstract][Full Text] [Related]
25. Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs.
Dill JA; Howlett AC
J Pharmacol Exp Ther; 1988 Mar; 244(3):1157-63. PubMed ID: 2855242
[TBL] [Abstract][Full Text] [Related]
26. Influence of plasma membrane depolarization on cAMP level in rat brain synaptosomes.
Fedorovich SV; Chubanov VS; Sholukh MV; Konev SV
Neuroreport; 1999 Jun; 10(8):1763-5. PubMed ID: 10501571
[TBL] [Abstract][Full Text] [Related]
27. Plasma and brain levels of delta 6-THC and seven monooxygenated metabolites correlated to the cataleptic effect in the mouse.
Ohlsson A; Widman M; Carlsson S; Ryman T; Strid C
Acta Pharmacol Toxicol (Copenh); 1980 Oct; 47(4):308-17. PubMed ID: 6258385
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.
Jeon YJ; Yang KH; Pulaski JT; Kaminski NE
Mol Pharmacol; 1996 Aug; 50(2):334-41. PubMed ID: 8700141
[TBL] [Abstract][Full Text] [Related]
29. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
30. Cannabinoid modulation of cyclic AMP accumulation in synaptosomes.
Little PJ; Martin BR
NIDA Res Monogr; 1989; 95():282-3. PubMed ID: 2561832
[No Abstract] [Full Text] [Related]
31. Chronic delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions.
Rubino T; Vigano' D; Massi P; Spinello M; Zagato E; Giagnoni G; Parolaro D
Neuropharmacology; 2000 Apr; 39(7):1331-6. PubMed ID: 10760375
[TBL] [Abstract][Full Text] [Related]
32. Effects of delta 1- and delta 6-tetrahydrocannabinol on the adenylate cyclase activity in ventricular tissue of the rat heart.
Li DM; Ng CK
Clin Exp Pharmacol Physiol; 1984; 11(1):81-5. PubMed ID: 6325054
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid ligand-receptor signaling in the mouse uterus.
Das SK; Paria BC; Chakraborty I; Dey SK
Proc Natl Acad Sci U S A; 1995 May; 92(10):4332-6. PubMed ID: 7753807
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity.
Martin BR; Kallman MJ; Kaempf GF; Harris LS; Dewey WL; Razdan RK
Pharmacol Biochem Behav; 1984 Jul; 21(1):61-5. PubMed ID: 6087379
[TBL] [Abstract][Full Text] [Related]
35. Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol.
Davis WM; Hatoum NS
Gen Pharmacol; 1983; 14(2):247-52. PubMed ID: 6301931
[TBL] [Abstract][Full Text] [Related]
36. Evidence that parathyroid hormone-mediated calcium transport in rat brain synaptosomes is independent of cyclic adenosine monophosphate.
Fraser CL; Sarnacki P; Budayr A
J Clin Invest; 1988 Apr; 81(4):982-8. PubMed ID: 2832450
[TBL] [Abstract][Full Text] [Related]
37. The facilitating and suppressing effects of delta 9-tetrahydrocannabinol on the rise in intrasynaptosomal Ca2+ concentration in rats.
Okada M; Urae A; Mine K; Shoyama Y; Iwasaki K; Fujiwara M
Neurosci Lett; 1992 Jun; 140(1):55-8. PubMed ID: 1328966
[TBL] [Abstract][Full Text] [Related]
38. In vitro activation of brain protein kinase C by the cannabinoids.
Hillard CJ; Auchampach JA
Biochim Biophys Acta; 1994 Jan; 1220(2):163-70. PubMed ID: 8312360
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the role of the phenolic hydroxyl in cannabinoid activity.
Reggio PH; Seltzman HH; Compton DR; Prescott WR; Martin BR
Mol Pharmacol; 1990 Dec; 38(6):854-62. PubMed ID: 2174506
[TBL] [Abstract][Full Text] [Related]
40. Role of cyclic AMP in the actions of cannabinoid receptors.
Childers SR; Deadwyler SA
Biochem Pharmacol; 1996 Sep; 52(6):819-27. PubMed ID: 8781498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
